PatrickHwuMD

Hematologic Oncology, Melanoma

Physician

Overview of Dr. Hwu

Dr. Patrick Hwu is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Medical College of Pennsylvania and has been in practice 30 years. He specializes in hematologic oncology and melanoma and is experienced in melanoma and cutaneous malignancies.

Office
12902 Magnolia Dr
CSB-8 CEO
Tampa, FL 33612
Book by Phone+1(620) 392-9899

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Johns Hopkins UniversityResidency, Internal Medicine, 1987 - 1989
MCP-Hahnemann College of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 2020 - 2025
TX State Medical License 2004 - 2025
OK State Medical License 2020 - 2021
MD State Medical License 1990 - 2004
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
Top Doctors:SE Texas Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Elected Member The American Society for Clinical Investigation, 2008
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer Start of enrollment: 1998 Feb 01
Completed
Phase 2
Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer Start of enrollment: 2001 Mar 01
Completed
Phase 1
Melanoma Vaccine With Peptides and Leuprolide Start of enrollment: 2005 Nov 01
Completed
Phase 2
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma Start of enrollment: 2006 Feb 01
Active, not recruiting
Phase 2
Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist Start of enrollment: 2010 May 20
Completed
Phase 2
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma Start of enrollment: 2015 Jan 28
Completed
Phase 1, Phase 2
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma Start of enrollment: 2014 Oct 15
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

60 citations
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, Heather Lin, Behrang Amini
The Lancet. Oncology. 2022-09-01
5867 citations
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian
The New England Journal of Medicine. 2012-06-28
53 citations
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.
Yan Yang, Chengwen Liu, Weiyi Peng, Gregory Lizée, Willem W. Overwijk
Blood. 2012-11-29

Journal Articles

Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients with Cancer
Michael J Overman, Adi Diab, Patrick Hwu, JAMA Network Open
Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma
Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
Join now to see all

Lectures

New Frontiers in Melanoma Management
The Johns Hopkins University School of Medicine, Baltimore, Maryland - 10/11/2012

Authored Content

Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients with CancerJuly 2020

Press Mentions

Singing Radiologist Pens Song to Clear up Confusion About Breast Cancer Screening RecsOctober 21st, 2024
Moffitt, AstraZeneca Partner on Cell Therapy DevelopmentSeptember 13th, 2024
Oncologists Celebrate the Legacy of Dr. Jeffrey S. Weber, “the Consummate Physician-Scientist”August 26th, 2024
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Health Alliance PPO
Health Net California Large Group PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select
Please verify your coverage with the provider's office directly when scheduling an appointment